Atlas Trials

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint Inhibitors

Clinical trial NCT06119347 · COMPLETED

Trial details

NCT number
NCT06119347
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Status
COMPLETED
Study type
OBSERVATIONAL
AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
Start date
2020-01-01
Primary completion
2023-06-30
Enrollment
1581

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.